載入...
Renin–angiotensin–aldosterone system (RAAS) pharmacogenomics: implications in heart failure management
Blockade of the renin–angiotensin–aldosterone system (RAAS) with ACE inhibitors has been a cornerstone of heart failure therapy for over 15 years. More recently, further blockade of RAAS with aldosterone antagonists and angiotensin receptor blockers (ARBs) has been studied. While these therapies hav...
Na minha lista:
| 發表在: | Heart Fail Rev |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013832/ https://ncbi.nlm.nih.gov/pubmed/18351457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10741-008-9092-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|